Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.
about
Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@en
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@nl
type
label
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@en
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@nl
prefLabel
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@en
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@nl
P2860
P1433
P1476
Management of Adverse Events A ...... erapy in Renal Cell Carcinoma.
@en
P2093
Manuela Schmidinger
Romano Danesi
P2860
P356
10.1634/THEONCOLOGIST.2017-0335
P577
2017-11-16T00:00:00Z